nivolumab
bms,medsir
['nadim', 'nsclc', 'nivo', 'sclc', 'nadimii', 'medsir']
amazing talk ! nadimii shows significant pcr improvement(or 7.88,p=0.0068)&amp;tolerable safety of neoadjuvant nivo+ct in resectable stage iiia-b nsclc. pd-l1 tps has predictive value for pcr(auc 0.728;p=0.002) a potential new soc in resectable nsclc!#asco22 
Bring your idea to life?? 
Creating successful IITs & optimizing drug development ?? 
Medica Scientia Innovation Research
 ????&????
https://t.co/yp3O5Lylqc